Related Experiment Video

Updated: Jan 25, 2026

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
06:12

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model

Published on: May 29, 2015

7.7K

Cascade-amplification of therapeutic efficacy: An emerging opportunity in cancer treatment

Menghuan Li1,2, Zhong Luo2, Zhihong Peng3

  • 1Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, China.

Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
|April 25, 2019
PubMed

Insights

Cancer treatment faces challenges from its complexity. A new cascade-amplification strategy combines therapies for enhanced anticancer activity, improving treatment efficacy.

Area of Science:

  • Oncologic Disease
  • Nanomedicine
  • Drug Discovery

Background:

  • Cancer's complexity involves multiple biological factors, limiting conventional single-target treatments.
  • Conventional monotonic anticancer approaches often show limited efficacy due to cancer's multifaceted nature.

Purpose of the Study:

  • To critically discuss the cascade-amplification strategy for cancer treatment.
  • To analyze the rational combination of therapeutic agents and their mechanisms within this strategy.
  • To evaluate the potential therapeutic benefits of cascade-amplification in various cancer indications.

Main Methods:

  • Review of existing research on synergistic therapeutic modalities.
  • Analysis of multi-target mechanisms and sequential drug action.
  • Discussion on rational combination of agents and their anticancer effects.

Main Results:

  • The cascade-amplification strategy enhances anticancer activity through multi-target mechanisms.
  • Synergistic combinations of therapeutic agents can overcome limitations of conventional treatments.
  • Sequential action of therapies targeting related pathways amplifies therapeutic effects.

Conclusions:

  • The cascade-amplification strategy offers a promising approach to improve cancer treatment efficacy.
  • Rational combination of therapies targeting multiple pathways is key to enhanced outcomes.
  • This strategy holds significant potential for nanomedicine in oncologic disease.
Keywords:
cascade-amplificationchemotherapyphotothermal/photodynamic therapyradiation therapysequential synergy

More Related Videos

In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer07:46

In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer

Published on: August 17, 2010

34.5K
Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

10.5K

Related Concept Videos

Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
53.5K
Rab Cascades01:25

Rab Cascades

Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.
3.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Emerging Adulthood01:27

Emerging Adulthood

Jeffrey Arnett's concept of emerging adulthood offers a framework to understand the unique developmental stage between adolescence and full-fledged adulthood, generally from ages 18 to 25. This period is marked by extensive exploration and shifts in identity, relationships, and career choices, a process known in psychology as role experimentation. Emerging adulthood reflects the evolving cultural expectations surrounding adulthood and the dynamic process of personal transformation during...
653
Cascaded Op Amps01:16

Cascaded Op Amps

Operational amplifiers (op-amps) are versatile electronic components that can be interconnected in a cascade - one after another in a linear sequence. This cascading is possible due to their infinite input resistance and zero output resistance, allowing them to maintain their input-output relationships even when connected in series.
In a cascaded system, each op-amp is referred to as a stage. The output of one stage drives the input of the subsequent stage. As the input signal passes through...
1.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.1K